RPRX in the 13F filings
Royalty Pharma PLC · CUSIP G7709Q104
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 8 May 2026
- Managers listing it
- 30
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 9 listed it in both
- Shares listed
- 77,812,482
- combined, among listed positions
- Reported value
- $3.7bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 18 buyers (opened or added shares) and 16 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +8,670,860.
Managers listing RPRX in Q1 2026
30 of 30 holders
Largest increases and reductions, by shares
Increases
- Capital World Investorsnew position · 8,036,714 shares now+8,036,714
- Invesco Ltdexisting position · 3,752,399 shares now+2,250,228
- Marshall Wace LLPexisting position · 2,120,692 shares now+1,723,954
- Two Sigma Investments LPexisting position · 2,251,525 shares now+1,570,277
- AQR Capital Management LLCexisting position · 3,782,038 shares now+1,218,384
Reductions
- Citadel Advisors LLCexisting position · 2,681,069 shares now-2,592,796
- Jane Street Group LLCexisting position · 2,400,382 shares now-2,547,027
- Arrowstreet Capital LPexisting position · 2,010,398 shares now-1,302,867
- Fidelity (FMR LLC)existing position · 25,152,242 shares now-1,120,066
- Baillie Gifford & Coexisting position · 16,155,677 shares now-853,091
New positions and exits
New (7)
Exited (4)
- Schonfeld Strategic Advisors LLCwas $4.6m
- Millennium Management LLCwas $4.5m
- Voloridge Investment Management LLCwas $3.9m
- Verition Fund Management LLCwas $3.7m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2020 | 10 | $1.8bn | n.a. | n.a. |
| Q3 2020 | 7 | $1.6bn | n.a. | n.a. |
| Q4 2020 | 5 | $1.9bn | n.a. | n.a. |
| Q1 2021 | 5 | $1.5bn | n.a. | n.a. |
| Q2 2021 | 8 | $1.5bn | n.a. | n.a. |
| Q3 2021 | 6 | $1.4bn | n.a. | n.a. |
| Q4 2021 | 8 | $1.8bn | n.a. | n.a. |
| Q1 2022 | 8 | $1.8bn | n.a. | n.a. |
| Q2 2022 | 10 | $3.2bn | n.a. | n.a. |
| Q3 2022 | 11 | $3.4bn | n.a. | n.a. |
| Q4 2022 | 17 | $3.4bn | n.a. | n.a. |
| Q1 2023 | 14 | $2.9bn | n.a. | n.a. |
| Q2 2023 | 16 | $2.3bn | n.a. | n.a. |
| Q3 2023 | 14 | $1.9bn | n.a. | n.a. |
| Q4 2023 | 13 | $2.1bn | 8 | 6 |
| Q1 2024 | 10 | $2.2bn | 5 | 6 |
| Q2 2024 | 12 | $1.7bn | 7 | 5 |
| Q3 2024 | 10 | $2.0bn | 7 | 4 |
| Q4 2024 | 10 | $1.6bn | 7 | 3 |
| Q1 2025 | 9 | $2.3bn | 4 | 5 |
| Q2 2025 | 9 | $2.4bn | 4 | 5 |
| Q3 2025 | 11 | $1.9bn | 7 | 5 |
| Q4 2025 | 10 | $2.4bn | 17 | 14 |
| Q1 2026 | 15 | $3.1bn | 18 | 16 |
| Q2 2026 | 15 | $3.9bn | 21 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
RPRX and LLY →RPRX and JNJ →RPRX and VRTX →Choose a stock to compare with RPRX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own RPRX, latest filings →Back to the 13F Explorer →